IRF1 and hepatocellular carcinoma: The ChIP assay showed that the IRF1-targeting ITLN1 promoter regions were immunoprecipitated by the antibody specific to IRF1 when compared to an unspecific antibody (isotype IgG) in cultured HCC cells (Fig. 5B).